Filtered By:
Condition: Guillain-Barr Syndrome

This page shows you your search results in order of date. This is page number 9.

Order by Relevance | Date

Total 314 results found since Jan 2013.

COVID-19 and neurologic manifestations: a synthesis from the child neurologist's corner
CONCLUSIONS: Various neurologic manifestations have been associated with children's SARS-CoV-2 infection. It is important to identify and give them proper and opportune treatment because they can be potentially grave and life-threatening; some can lead to long-lasting sequelae. Different neuro-pathophysiological mechanisms have been proposed, however, a causal relationship between SARS-CoV-2 infection and neurologic manifestations remains to be proven. Patients with neurologic diseases are especially affected by COVID-19, not only by the disease itself but also by its complications and pandemic management measures.PMID:354...
Source: World Journal of Pediatrics : WJP - April 27, 2022 Category: Pediatrics Authors: Carolina Valderas Gast ón Méndez Alejandra Echeverr ía Nelson Suarez Katherin Julio Francisca Sandoval Source Type: research

Neurological manifestations of COVID ‐19: A potential gate to the determinants of a poor prognosis
ConclusionCOVID-19 neurologic complications are key drivers of patient severity and mortality. Headache, convulsions, mental and psychic disorders, delirium, and insomnia are just some of the symptoms that the virus can cause. The olfactory nerve is the most commonly damaged cranial nerve, resulting in anosmia. Stroke (mostly infarction), encephalitis, meningitis, Guillain –Barre syndrome, relapse of multiple sclerosis, and transverse myelitis are all symptoms and squeals.
Source: Brain and Behavior - April 27, 2022 Category: Neurology Authors: Etedal Ahmed A. Ibrahim, Ramah Isam Farah Hassan, Khabab Abbasher Hussien Mohamed Ahmed, Elmuntasir Taha Salah, Mohammed Eltahier Abdalla Omer, Mazin S. Haroun Tags: REVIEW Source Type: research

Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic
CONCLUSION: Rates of some clinical outcomes during the pandemic changed and should not be used as historical background rates in vaccine safety studies. Inclusion of telehealth visits should be considered for vaccine studies involving Bell's palsy, ITP, and narcolepsy/cataplexy.PMID:35465977 | DOI:10.1016/j.vaccine.2022.04.037
Source: Vaccine - April 25, 2022 Category: Allergy & Immunology Authors: Stanley Xu Vennis Hong Lina S Sy Sungching C Glenn Denison S Ryan Kerresa L Morrissette Jennifer C Nelson Simon J Hambidge Bradley Crane Ousseny Zerbo Malini B DeSilva Jason M Glanz James G Donahue Elizabeth Liles Jonathan Duffy Lei Qian Source Type: research

Guillain-Barre syndrome in Mexico: clinical features and validation of Brighton Collaboration Group criteria
CONCLUSION: GBS is a frequent autoimmune neuropathy that has been associated with preceding infections and with vaccination campaigns. For SARS-CoV-2 vaccination campaign in Mexico, validation of Brighton Criteria is necessary. Although Mexico's GBS epidemiology has been changing throughout recent years, this study provides similar data compared to other countries.PMID:35383873 | DOI:10.33588/rn.7408.2021437
Source: Revista de Neurologia - April 6, 2022 Category: Neurology Authors: J C L ópez-Hernández J A Galnares-Olalde A Guti érrez S A Estrada M Garc ía-Grimshaw E S Vargas-Ca ñas Source Type: research